Literature DB >> 29724875

Unusual case of anti-N-methyl-D-aspartic acid-receptor (NMDA-R) encephalitis and autoimmune polyglandular syndrome (APS).

Simona Frunza-Stefan1, Hilary B Whitlatch1, Gautam G Rao2, Rana Malek1.   

Abstract

Anti-N-methyl-D-aspartic acid-receptor (NMDA-R) encephalitis is a novel disease discovered within the past 10 years. It is an autoimmune disease (AD) that has been associated with other ADs, such as Graves' disease. However, association with autoimmune polyglandular syndromes (APS) has not been previously described. A 58-year-old woman presented with altered mental status and an 8-month history of weight loss, apathy and somnolence. Laboratory evaluation confirmed Graves' disease with thyrotoxicosis and type 1 diabetes mellitus. Despite treatment, she continued to have a fluctuating mental status. Further diagnostic evaluation included an abdominal MRI that showed a cystic lobular left adnexal mass. Serum anti-NMDA-R antibodies were positive, raising concern for NMDA-R encephalitis. Bilateral salpingo-oophorectomy was performed, with pathology consistent with cystadenofibroma. She had a favourable recovery with marked clinical improvement. Anti-NMDA-R antibodies were negative 2 months following surgery. The concomitant occurrence of APS and anti-NMDA-R encephalitis suggests a shared mechanism of autoimmune pathophysiology. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  diabetes; thyroid disease

Mesh:

Substances:

Year:  2018        PMID: 29724875      PMCID: PMC5935153          DOI: 10.1136/bcr-2018-224821

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  32 in total

1.  Polyglandular autoimmune syndrome type II and multiple sclerosis.

Authors:  J Sastre-Garriga; M Tintoré; X Montalban
Journal:  J Neurol       Date:  2001-04       Impact factor: 4.849

2.  Cognitive deficits following anti-NMDA receptor encephalitis.

Authors:  Carsten Finke; Ute A Kopp; Harald Prüss; Josep Dalmau; Klaus-Peter Wandinger; Christoph J Ploner
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-09-20       Impact factor: 10.154

3.  Prevalence and treatment of anti-NMDA receptor encephalitis.

Authors:  Zuzana Liba; Vera Sebronova; Vladimir Komarek; Anna Sediva; Petr Sedlacek
Journal:  Lancet Neurol       Date:  2013-05       Impact factor: 44.182

4.  Anti-N-methyl-d-aspartate encephalitis with ovarian cystadenofibroma.

Authors:  Oranee Sanmaneechai; Joo Lee Song; Nicole Nevadunsky; Solomon L Moshé; Philip J Overby
Journal:  Pediatr Neurol       Date:  2013-03       Impact factor: 3.372

5.  Recommended diagnostic criteria for paraneoplastic neurological syndromes.

Authors:  F Graus; J Y Delattre; J C Antoine; J Dalmau; B Giometto; W Grisold; J Honnorat; P Sillevis Smitt; Ch Vedeler; J J G M Verschuuren; A Vincent; R Voltz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

6.  Expanding spectrum of encephalitis with NMDA receptor antibodies in young children.

Authors:  Axel Lebas; Béatrice Husson; Adrien Didelot; Jerôme Honnorat; Marc Tardieu
Journal:  J Child Neurol       Date:  2009-10-15       Impact factor: 1.987

7.  A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic.

Authors:  L J Edwards; C S Constantinescu
Journal:  Mult Scler       Date:  2004-10       Impact factor: 6.312

8.  Neurologic consequences of autoimmune polyglandular syndrome type 1.

Authors:  Joseph R Berger; Allison Weaver; John Greenlee; George E Wahlen
Journal:  Neurology       Date:  2008-06-03       Impact factor: 9.910

Review 9.  Autoimmune encephalitis: recent updates and emerging challenges.

Authors:  Sudarshini Ramanathan; Shekeeb S Mohammad; Fabienne Brilot; Russell C Dale
Journal:  J Clin Neurosci       Date:  2013-09-15       Impact factor: 1.961

Review 10.  APECED: A Paradigm of Complex Interactions between Genetic Background and Susceptibility Factors.

Authors:  Lucia De Martino; Donatella Capalbo; Nicola Improda; Federica D'Elia; Raffaella Di Mase; Roberta D'Assante; Ida D'Acunzo; Claudio Pignata; Mariacarolina Salerno
Journal:  Front Immunol       Date:  2013-10-23       Impact factor: 7.561

View more
  1 in total

1.  Testing for Thyroid Peroxidase and Antineuronal Antibodies in Depression and Schizophrenia.

Authors:  Johann Steiner; Winfried Stoecker; Bianca Teegen; Henrik Dobrowolny; Gabriela Meyer-Lotz; Katrin Borucki; Paul C Guest; Hans-Gert Bernstein
Journal:  Methods Mol Biol       Date:  2022
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.